• ADBiotech plans to issue KRW 1 billion of unregistered, unsecured convertible bonds through a private placement.
• Proceeds will fund acquisitions of securities in other companies.
• The bonds carry a 6% annual coupon and mature Nov. 6, 2029; payment is scheduled for Nov. 6, 2026.
• Conversion at KRW 1,999 per share could create 500,250 common shares, representing 1.58% of total shares.
• Bondholders can seek early redemption starting Nov. 6, 2027; the issuer's call option covers up to 50% of the issuance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADBiotech Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261029000674), on October 30, 2026, and is solely responsible for the information contained therein.